ABSTRACT: Polymyxin is the last-line therapy against Gram-negative ‘superbugs’; however, dose-limiting nephrotoxicity can occur in up to 60 % of patients after intravenous administration. Understanding the accumulation and concen-tration of polymyxin within renal tubular cells is essential for the development of novel strategies to ameliorate its nephrotoxicity and to develop safer, new polymyxins. We designed and synthesized a novel dual-modality iodine-labeled fluorescent probe for quantitative mapping of polymyxin in kidney proximal tubular cells. Measured by synchrotron X-ray fluorescence microscopy, polymyxin concentrations in single rat (NRK-52E) and human (HK-2) kidney tubular cells were approximately 1930- to 4760-fold higher than e...
AbstrACt Polymyxins are polypeptide antibiotics with strong action against Gram-negative bacteria. T...
The emergence of very multiresistant Gram-negative bacterial strains has reinstated polymyxins (poly...
The polymyxin lipodecapeptides colistin and polymyxin B have become last resort therapies for infect...
Polymyxins are cyclic lipopeptide antibiotics that serve as a last line of defense against Gram-nega...
This thesis examined the mechanism of nephrotoxicity of the last-resort polymyxins using a systems a...
Objective: Increasing prevalence of multidrug resistant Gram-negative infections has led to renewed ...
Colistin and polymyxin B are effective treatment options for Gram-negative resistant bacteria but ar...
Identifying the pathways involved in the apoptotic cell death that is associated with polymyxin-indu...
The aim of the study was to characterize the cell damage mechanisms involved in the pathophysiology ...
Identifying the pathways involved in the apoptotic cell death that is associated with polymyxin-indu...
Polymyxins are last-line antibiotics for the treatment of Gram-negative ‘superbugs’. However, nephro...
Objectives: Despite dose-limiting nephrotoxic potentials, polymyxin B has re-emerged as the last lin...
Polymyxins have a long history of dose-limiting toxicity, but the underlying mechanism of polymyxin ...
Thesis (Ph.D.)--University of Washington, 2018Late-stage attrition of investigational new drugs can ...
Antibiotics underpin modern medicine; however, the emergence of multi-drug resistant bacterial ‘supe...
AbstrACt Polymyxins are polypeptide antibiotics with strong action against Gram-negative bacteria. T...
The emergence of very multiresistant Gram-negative bacterial strains has reinstated polymyxins (poly...
The polymyxin lipodecapeptides colistin and polymyxin B have become last resort therapies for infect...
Polymyxins are cyclic lipopeptide antibiotics that serve as a last line of defense against Gram-nega...
This thesis examined the mechanism of nephrotoxicity of the last-resort polymyxins using a systems a...
Objective: Increasing prevalence of multidrug resistant Gram-negative infections has led to renewed ...
Colistin and polymyxin B are effective treatment options for Gram-negative resistant bacteria but ar...
Identifying the pathways involved in the apoptotic cell death that is associated with polymyxin-indu...
The aim of the study was to characterize the cell damage mechanisms involved in the pathophysiology ...
Identifying the pathways involved in the apoptotic cell death that is associated with polymyxin-indu...
Polymyxins are last-line antibiotics for the treatment of Gram-negative ‘superbugs’. However, nephro...
Objectives: Despite dose-limiting nephrotoxic potentials, polymyxin B has re-emerged as the last lin...
Polymyxins have a long history of dose-limiting toxicity, but the underlying mechanism of polymyxin ...
Thesis (Ph.D.)--University of Washington, 2018Late-stage attrition of investigational new drugs can ...
Antibiotics underpin modern medicine; however, the emergence of multi-drug resistant bacterial ‘supe...
AbstrACt Polymyxins are polypeptide antibiotics with strong action against Gram-negative bacteria. T...
The emergence of very multiresistant Gram-negative bacterial strains has reinstated polymyxins (poly...
The polymyxin lipodecapeptides colistin and polymyxin B have become last resort therapies for infect...